BioSpace News Archive

Soligenix, Inc. announced today that Dr. Oreola Donini, Chief Scientific Officer, will be presenting preclinical and clinical data illustrating the potential utility of the Innate Defense Regulator technology in the treatment of infectious disease in a poster session at the upcoming European Society of Clinical Microbiology and Infectious Diseases / American Society of Microbiology Conference

Concord Medical Services Holdings Limited today announced its unaudited consolidated financial results for the six months ended June 30, 2018[1].

TapImmune Inc. will participate at two upcoming industry conferences.

SCYNEXIS, Inc. announced that the Company will participate in the following upcoming investor conferences:

Impel NeuroPharma, a Seattle-based, privately-held biopharmaceutical company focused on therapies for the treatment of central nervous system (CNS) disorders, today announced the first subject has been dosed in a Phase 1, randomized, double-blind, placebo-and-active controlled crossover study of their intranasal olanzapine product

Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that Michel Sadelain, M.D., Ph.D., has been appointed a member of its Strategic Scientific Advisory Board (SSAB).

Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018 at 5:05 p.m. EDT at the St. Regis New York Hotel in New York, NY.

bluebird bio, Inc. today announced that members of the management team will present at the following upcoming investor conferences:

SCORR Marketing, the leading full-service marketing and communications firm in the health science industry, has announced the promotion of Krystle Buntemeyer to president.

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members of senior management will present at three investor conferences in Septembe